N
NimbleRx
Provides a pharmacy experience centered around the patient's needs to provide a more streamlined workflow
About NimbleRx
NimbleRx operates in the healthcare technology sector, providing a comprehensive platform for pharmacies to manage prescriptions, refills, payments, and deliveries. The company serves both independent and chain pharmacies, aiming to streamline their operations and improve patient care. NimbleRx's business model revolves around offering a subscription-based service that integrates seamlessly with existing pharmacy systems. This platform allows pharmacies to efficiently handle prescription orders, automate refills, manage compliance, and execute marketing strategies. By doing so, NimbleRx helps pharmacies reduce operational costs, increase revenue, and enhance customer satisfaction. The company generates revenue through subscription fees and potentially transaction-based charges for certain services. NimbleRx operates primarily in the United States, targeting pharmacies that seek to modernize their operations and offer better service to their patients. The platform is designed to be user-friendly, ensuring that pharmacists can easily adopt and utilize its features without extensive training. Key features include 24/7 prescription management, secure information storage, and options for discreet delivery or in-store pickup. NimbleRx also provides robust customer support to address any questions or issues that pharmacies might encounter. Overall, NimbleRx positions itself as a vital partner for pharmacies looking to enhance their operational efficiency and patient care capabilities.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Redwood City, United States
- Employees
- 170
- Open positions
- 7
- Dealroom signal
- 80.5/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Pharmacy, Biotechnology, Biotech and Pharma, Hard Tech, YC W15
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | May 2026 | $0 | — | Swoop | ↗ |
| LATE VCOther financing | Jul 2022 | $25M | $100M | Undisclosed | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for NimbleRx is 2.2M monthly website visits, up 15.8% over the last three months. NimbleRx's team declined 5.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
Series A5 investors entered at this stage
Series B and later1 investor entered at this stage
- FGFour Rivers Group
Other known investors1 additional known investor
Swoop
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NimbleRx on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NimbleRx’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.














